ZYBT Stock Analysis: Buy, Sell, or Hold?
ZYBT - Zhengye Biotechnology Holding Limited Ordinary Shares
$0.85
0.01 (0.83%)
▲
5d:
-15.0%
30d:
+6.25%
90d:
-44.44%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Get Alerted When ZYBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ZYBT is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ZYBT is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ZYBT is currently trading at $0.85, which is considered fair relative to its 30-day fair value range of $0.74 to $0.91.
Technical Outlook: Technically, ZYBT is in a strong downtrend. Immediate support is located at $0.71, while resistance sits at $1.20.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZYBT is in a strong downtrend. Immediate support is located at $0.71, while resistance sits at $1.20.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.74 -
$0.91
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
65.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- WARNING: Recommendation downgraded due to -15.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.74 -
$0.91
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.71
Resistance Level
$1.20
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Revenue Growth (YoY)
-34.4%
Earnings Growth (YoY)
-79.6%
Profit Margin
-12.6%
Share & Embed Analysis
Last updated: March 30, 2026 5:58 PM ET
Data refreshes hourly during market hours. Next update: 6:58 PM
Data refreshes hourly during market hours. Next update: 6:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZYBT showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 55 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 63 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 56 HOLD |
